Loading clinical trials...

Observation Study of the Clinical Management of Bipolar Disorder | Clinical Trials | Clareo Health

COMPLETED

Observation Study of the Clinical Management of Bipolar Disorder

Chinese Observation Study of the Clinical Management of Bipolar Disorder

NCT01770704•AstraZeneca

Summary

The objective of the ambispective cohort study is to describe clinical management and clinical outcomes related to bipolar disorder in China, and establish the factors associated with different management patterns and clinical outcomes, provide psychiatrists with reliable and up-to-date information on the disease.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Provision of subject informed consent.
•Diagnosis of Bipolar Disorder I or II (DSM-IV TR) in any phase of the disorder.
•Patients who had at least one mood event( depression, mania, hypomania or mixed) according to DSM-IV TR definition during the 3 and 12 months prior to the beginning of the study.

Exclusion Criteria

•Inability to complete Patient Reported Outcomes (PROs) questionnaires.
•Participation in an interventional clinical study in last 12 months.

Locations (6)

Research Site

Beijing, Beijing Municipality, China

Research Site

Shenzhen, Guangdong, China

Reserach Site

Shanghai, Shanghai Municipality, China

Research Site

Xi’an, Shanxi, China

Research SIte

Kunming, Yunnan, China

Research Site

Hangzhou, Zhejiang, China

Key Dates

Start Date

February 1, 2013

Primary Completion Date

July 1, 2014

Completion Date

July 1, 2014

Last Updated

April 7, 2016

Enrollment

520

ACTUAL participants

Conditions

Bipolar Disorder

University of Iowa Interventional Psychiatry Service Patient Registry

NCT04480918

Treatment Resistant DepressionMajor Depressive Episode+5 more

View study

RECRUITINGPHASE3

A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine

NCT07140913

ManiaBipolar Disorder

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 7, 2016Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Observation Study of the Clinical Management of Bipolar Disorder

Inclusion Criteria

Exclusion Criteria

University of Iowa Interventional Psychiatry Service Patient Registry

A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine

Epigenetic Enhancement of Cognitive Training in Aging Mood Disorder Populations

CBT-CP for Veterans With SMI

A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)

Early Intervention for Youth at High Risk for Bipolar Disorder